Conversion of CellCept [mycophenolate mofetil] to Myfortic [mycophenolic acid]: A prospective study on the tolerability and safety of Myfortic in liver transplant recipients
Phase of Trial: Phase II
Latest Information Update: 11 Nov 2016
At a glance
- Drugs Mycophenolate sodium (Primary) ; Mycophenolate mofetil; Mycophenolic acid
- Indications Liver transplant rejection
- Focus Adverse reactions
- 03 Nov 2016 Status changed from recruiting to completed.
- 13 Nov 2006 Status change
- 25 Oct 2006 New trial record.